Clinical trial
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism…
NCT00007020 · Mirum Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00007020 |
|---|---|
| Title | Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid |
| Official title | Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism |
| Lead sponsor | Mirum Pharmaceuticals, Inc., Industry |
| Collaborators | Children's Hospital Medical Center, Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infantile Refsum's Disease, Zellweger Syndrome, Adrenoleukodystrophy, Peroxisomal Disorders, Cholestasis |
| Intervention type | Drug |
| Interventions | Cholic Acids |
| Enrollment | 85 |
| Start date | Jan 1, 1992 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Dec 7, 2000 |
| Last update posted | Oct 3, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: